Antibodies that fight Ebola viruses are now a reality

Ebola virus disease was first reported in Central Africa in 1976; it has the potential to cause massive bleeding. The mortality rate is about 50%. The virus is transmitted by contact with contaminated body fluids, including blood and semen.   Finally, antibodies against three of the major Ebola viruses were developed. Researchers at Vanderbilt University Medical Center have come one step closer to developing a highly effective antibody treatment against these viruses that cause deadly diseases in humans.   The researchers found that the isolation of two potent monoclonal antibodies…

Read More